65 related articles for article (PubMed ID: 7166750)
1. Different human hematopoetic cell lines, susceptible or resistant to NK lysis, conjugate identically to non-adherent peripheral blood lymphocytes.
Ullberg M; Jondal M
J Clin Lab Immunol; 1982 Dec; 9(3):177-83. PubMed ID: 7166750
[TBL] [Abstract][Full Text] [Related]
2. Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.
Ullberg M; Jondal M
Clin Exp Immunol; 1983 Jul; 53(1):101-8. PubMed ID: 6872324
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells kill human retinoblastoma cells.
Ohashi Y; Sasabe T; Nishida T; Manabe R
Jpn J Ophthalmol; 1984; 28(4):370-6. PubMed ID: 6085129
[TBL] [Abstract][Full Text] [Related]
4. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
5. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous cytotoxicity against virus-infected cells: relationship to NK against uninfected cell lines and to ADCC.
Weston PA; Jensen PJ; Levy NL; Koren HS
J Immunol; 1981 Mar; 126(3):1220-4. PubMed ID: 6257784
[TBL] [Abstract][Full Text] [Related]
7. Identification and separation by bacterial adherence of human lymphocytes that suppress natural cytotoxicity.
DeBoer KP; Kleinman R; Teodorescu M
J Immunol; 1981 Jan; 126(1):276-81. PubMed ID: 6969743
[TBL] [Abstract][Full Text] [Related]
8. A single cell marker of active NK cytotoxicity: only a fraction of target binding lymphocytes are killer cells.
Targan S; Grimm E; Bonavida B
J Clin Lab Immunol; 1980 Nov; 4(3):165-8. PubMed ID: 7205938
[TBL] [Abstract][Full Text] [Related]
9. [Morphological observation on NK/LAK cell-mediated lysis of human oral carcinoma cells].
Zheng YJ; Zhang J; Wang SM; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):392-6. PubMed ID: 15090306
[TBL] [Abstract][Full Text] [Related]
10. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
[TBL] [Abstract][Full Text] [Related]
11. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
Horvath-Arcidiacono JA; Porter CM; Bloom ET
Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis.
Kubista B; Trieb K; Blahovec H; Kotz R; Micksche M
Anticancer Res; 2002; 22(2A):789-92. PubMed ID: 12014651
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
16. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
17. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
[TBL] [Abstract][Full Text] [Related]
18. Isolation of human spontaneous killer lymphocytes by bacterial adherence.
Kleinman R; De Boer KP; Teodorescu M
Clin Exp Immunol; 1980 Feb; 39(2):510-8. PubMed ID: 7389207
[TBL] [Abstract][Full Text] [Related]
19. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
20. Different E-rosetting properties of human peripheral blood NK- and K-cells.
Jantscheff P; Milleck J; Thränhardt H
Arch Geschwulstforsch; 1986; 56(5):335-9. PubMed ID: 3767602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
